Rankings
▼
Calendar
MRVI FY 2024 Earnings — Maravai LifeSciences Holdings, Inc. Revenue & Financial Results | Market Cap Arena
MRVI
Maravai LifeSciences Holdings, Inc.
$999M
FY 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$259M
-10.3% YoY
Gross Profit
$108M
41.8% margin
Operating Income
-$236M
-90.9% margin
Net Income
-$145M
-55.9% margin
EPS (Diluted)
$-1.05
Cash Flow
Operating Cash Flow
$7M
Free Cash Flow
-$22M
Stock-Based Comp.
$49M
Balance Sheet
Total Assets
$1.0B
Total Liabilities
$431M
Stockholders' Equity
$325M
Cash & Equivalents
$322M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$259M
$289M
-10.3%
Gross Profit
$108M
$140M
-22.7%
Operating Income
-$236M
-$32M
-644.5%
Net Income
-$145M
-$119M
-21.7%
← Q4 2023
All Quarters
Q1 2024 →